COMBINED EPIGENETIC REPROGRAMMING AND IMMUNOTHERAPY TO TACKLE HIGH-RISK MULTIPLE MYELOMA MODIFICATION P00001 INCORPORATED TRANSFER OF AWARD ON 08/06/25

Rush University Medical Center, Chicago IL

Investigators